ArticleJournal of health economics and outcomes research2023

Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm.

Scott Goulden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.